Newsroom

Recent news, statements, and resources

Newsroom

Recent news, statements, and resources

Welcome to The Leukemia & Lymphoma Society Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

Sunbelt Rentals Announces Partnership with The Leukemia & Lymphoma Society to Help Blood Cancer Patients and Their Families

December 12, 2024

From left to right: Dr. Lee Greenberger, LLS Chief Scientific Officer; LLS Excellence in Scientific Service award winners, Dr. Jonathan Licht and Dr. Susan O’Brien.

The Leukemia & Lymphoma Society Honors 6 Scientists for their Contributions to Blood Cancer Research at Event During American Society of Hematology Annual Meeting

December 9, 2024

Image of text that reads "Breaking News" over leukemia cells.

FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia

December 6, 2024

Image of text that reads "Breaking News" over blood cancer cells.

New Formulation of Important CML Drug Comes with No Mealtime Restrictions

December 6, 2024

Image of text that reads "Breaking News" over blood cancer cells.

Oral Formulation of Methotrexate Now Available for Children with Leukemia Subtype

December 6, 2024

Image of text that reads "Breaking News" over leukemia cells.

FDA Approves a CAR T-cell Therapy to Treat Adults with a Form of Acute Leukemia

December 6, 2024

Image of text that reads "Breaking News" over leukemia cells.

FDA Approves First of a New Class of Drugs to Treat Advanced Acute Leukemia

December 6, 2024

An image depicting tablets and laptops with text that reads news

The Leukemia & Lymphoma Society (LLS) Data at ASH Provides Glimpse into the Future of Blood Cancer Treatment

November 20, 2024

John Crispino, Ph.D., of St. Jude Children’s Research Hospital, stands for a photo in a laboratory.

The Leukemia & Lymphoma Society 2025 Research Grants Include Acute Leukemia in Children with Down Syndrome

November 14, 2024

Media Requests

For all media-related inquiries and interview requests please email mediarelations@lls.org. An LLS representative will respond as soon as possible.